(Q37988213)

26 August 2017

title

Nanomedicine and veterinary science: the reality and the practicality (English)

1 reference

26 August 2017

1 reference

C Underwood

1

1 reference

26 August 2017

A W van Eps

series ordinal

2

1 reference

26 August 2017

publication date

24 February 2012

1 reference

26 August 2017

published in

The Veterinary Journal

1 reference

26 August 2017

volume

193

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

12-23

1 reference

Nanomaterial standards for efficacy and toxicity assessment

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Intra-articular drug delivery: a fast growing approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Use of liposome-immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preparation, characterization, and biodistribution study of technetium-99m -labeled leuprolide acetate-loaded liposomes in Ehrlich ascites tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Toxicity of silver nanoparticles in zebrafish models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Adjuvants designed for veterinary and human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Long-circulating sterically stabilized liposomes in the treatment of infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-mediated uptake of exogenous DNA by equine spermatozoa and applications in sperm-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanomedicine: magnetic nanoparticles and their biomedical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preliminary data on efficacy of Mycoplasma gallisepticum vaccines containing different adjuvants in laying hens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Quantum dots for in vivo small-animal imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: preliminary experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Multifunctional micellar nanomedicine for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Solid lipid nanoparticles for targeted brain drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Lipid nanoparticles for drug delivery to the brain: in vivo veritas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Kinetic behavior of three preparations of alpha-tocopherol after oral administration to postpubertal heifers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Comparison of high (5%) and low (1%) concentrations of micellar microemulsion propofol formulations with a standard (1%) lipid emulsion in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Pharmacokinetic profile in relation to anaesthesia characteristics after a 5% micellar microemulsion of propofol in the horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Controlled release technologies for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanoparticles in cancer therapy and diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic toxic effects on embryonic developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Photodynamic Therapy of Feline Cutaneous Squamous Cell Carcinoma Using a Newly Developed Liposomal Photosensitizer: Preliminary Results Concerning Drug Safety and Efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Effect of topical application of diclofenac liposomal suspension on experimentally induced subcutaneous inflammation in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

An appraisal of the published literature on the safety and toxicity of food-related nanomaterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Immunogenicity of synthetic Rhodococcus equi virulence-associated protein peptides in neonate foals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanotechnology and the transdermal route: A state of the art review and critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Acute toxicological effects of copper nanoparticles in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Pharmacokinetic and pharmacodynamic evaluation of propofol administered to cats in a novel, aqueous, nano-droplet formulation or as an oil-in-water macroemulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

The disposition of free and niosomally encapsulated Rac-flurbiprofen in dairy bovines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Low-level detection of viral pathogens by a surface-enhanced Raman scattering based immunoassay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-encapsulated Muramyl Tripeptide Phosphatidylethanolamine for the Treatment of Feline Mammary Adenocarcinoma-A Multicenter Randomized Double-blind Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Intestinal mucosal immune response in chickens following intraocular immunization with liposome-associated Salmonella enterica serovar enteritidis antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Gold nanoparticles in delivery applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vascular-targeted nanoparticles for molecular imaging and therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanoparticle detection of respiratory infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

In vivo quantum-dot toxicity assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Developmental toxicity of low generation PAMAM dendrimers in zebrafish.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposomal encapsulated anti-cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Clinical potential of quantum dots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Intra-tumoral Gene Delivery of feIL-2, feIFN-γ and feGM-CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase-I Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Au nanoparticles target cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Toxicity and tissue distribution of magnetic nanoparticles in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Concomitant liposomal doxorubicin and daily palliative radiotherapy in advanced feline soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Role of nanotechnology in targeted drug delivery and imaging: a concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A biosensor assay for the detection of Mycobacterium avium subsp. paratuberculosis in fecal samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Microemulsion-based media as novel drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Effect of topical application of 1% diclofenac sodium liposomal cream on inflammation in healthy horses undergoing intravenous regional limb perfusion with amikacin sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Suppression of Salmonella enterica serovar Enteritidis excretion by intraocular vaccination with fimbriae proteins incorporated in liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Efficacy of the liposome trifluralin in the treatment of experimental canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preclinical and clinical studies of anticancer agent-incorporating polymer micelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

The role of liposomes in drug delivery and diagnostic imaging: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Current status and potential application of ISCOMs in veterinary medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Ranking initial environmental and human health risk resulting from environmentally relevant nanomaterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A risk assessment framework for assessing metallic nanomaterials of environmental concern: aquatic exposure and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Molecular engineering of dendritic polymers and their application as drug and gene delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Gene delivery using functional dendritic polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of liposome-encapsulated butorphanol tartrate for alleviation of experimentally induced arthritic pain in green-cheeked conures (Pyrrhura molinae)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Analgesic effects of carprofen and liposome-encapsulated butorphanol tartrate in Hispaniolan parrots (Amazona ventralis) with experimentally induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanotech approaches to drug delivery and imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Virus-sized vaccine delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Systemic immune responses in sheep, induced by a novel nano-bead adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposome-based diclofenac for the treatment of inflammation in an acute synovitis model in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Metal‐based nanoparticles and their toxicity assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Physiological effects of nanoparticles on fish: a comparison of nanometals versus metal ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Characterization and application of quantum dot nanocrystal-monoclonal antibody conjugates for the determination of sulfamethazine in milk by fluoroimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Liposomal diamidine (imidocarb): preparation and animal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Polymeric systems for controlled drug release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Low-energy nanoemulsification to design veterinary controlled drug delivery devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of a novel immunotherapy for treatment of chronic rhinitis in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

The emerging nanomedicine landscape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Formulation of novel nano-encapsulated Newcastle disease vaccine tablets for vaccination of village chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Effect of chromium nanocomposite supplementation on growth hormone pulsatile secretion and mRNA expression in finishing pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Effects of copper-loaded chitosan nanoparticles on growth and immunity in broilers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Investigation of escalating and large bolus doses of a novel, nano-droplet, aqueous 1% propofol formulation in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Vaccination of chickens with liposomal inactivated avian pathogenic Escherichia coli (APEC) vaccine by eye drop or coarse spray administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Polymeric micelles as a new drug carrier system and their required considerations for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Monolayer-protected nanoparticle-protein interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Multicolor quantum dot-encoded microspheres for the fluoroimmunoassays of chicken newcastle disease and goat pox virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Phase-transition polymers for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

A liposome immune lysis assay for enrofloxacin in carp and chicken muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

DNA–chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Toxicology of nanomaterials used in nanomedicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2012.01.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TVJL.2012.01.002

1 reference

26 August 2017

1 reference